Sensible Bio: Building the Production Layer for the Next Generation of Medicine
We are pleased to announce OTB Ventures’ investment in Sensible Biotechnologies’ $15 million Series A round, which we co-led alongside Oxford Science Enterprises, with participation from Isomer Capital, In-Q-Tel, Recode Ventures, Backed VC, Kaya VC, Civilization Ventures and Y Combinator. Sensible is Building the Production Layer for the Next Generation of Medicine mRNA proved itself […]
We are so happy to announce that we have won in 3 categories at the annual CEE X-Tech Awards!
🏆 FinTech Company of the Year: